@article {Gabster2021.10.28.21265606, author = {Amanda Gabster and Monica Jhangimal and Jennifer Toller Erausquin and Jos{\'e} Antonio Su{\'a}rez and Justo Pinz{\'o}n-Espinosa and Madeline Baird and Jennifer Katz and Davis Beltran-Henr{\'\i}quez and Gonzalo Cabezas-Talavero and Andr{\'e}s F. Henao-Mart{\'\i}nez and Carlos Franco-Paredes and Nelson I. Agudelo-Higuita. and M{\'o}nica Pachar and Jos{\'e} Anel Gonz{\'a}lez and F{\'a}tima Rodriguez and Juan Miguel Pascale and Migrant Peoples in Transit Study Group}, title = {Rapid health evaluation in migrant peoples in transit through Darien, Panama: Protocol for a multi-method qualitative and quantitative study}, elocation-id = {2021.10.28.21265606}, year = {2021}, doi = {10.1101/2021.10.28.21265606}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background The world is currently unprepared to deal with a the drastic increase in global migration. There is an urgent need to develop programs to protect the well being and health of migrant peoples. Increased population movement is already evident throughout the Americas as exemplified by the rising number of migrant peoples that pass through the Darien neotropical moist broadleaf forest along the border region between Panama and Colombia. The transit of migrant peoples through this area has an increase in the last years. In 2021 an average of 9,400 people entered the region per month compared to 2,000-3,500 people monthly in 2019. Along this trail, there is no access to healthcare, food provision, potable water, or housing. To date, much of what is known about health needs and barriers to healthcare within this population is based on journalistic reports and anecdotes. There is a need for a comprehensive approach to assess the healthcare needs migrant peoples in transit. This study aims to describe demographic characteristics, mental and physical health status and needs, and experiences of host communities, and to identify opportunities to improve healthcare provision to migrant peoples in transit in Panama.Study design and methods This multi-method study will include qualitative (n=70) and quantitative (n=520) components. The qualitative component includes interviews with migrant peoples in transit, national and international non-governmental organizations and agencies based in Panama. The quantitative component is a rapid epidemiological study which includes a questionnaire and four clinical screenings: mental health, sexual and reproductive health, general and tropical medicine, and nutrition.Conclusion This study will contribute to a better understanding of the health status and needs of migrant peoples in transit through the region. Findings will be used to allocate resources and provide targeted healthcare interventions for migrant peoples in transit through Darien, Panama.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding is provided by Instituto Conmemorativo Gorgas de Estudios de la Salud (Panama), Community Development Network of the Americas, Acino Swiss Farma (donation), Neglected Tropical Diseases Fund and University of Colorado (donation by Mr. Howard Janzen). Additional donations have come from Sagrav SA and Omega Diagnostics, and a large proportion of the diagnostic tests have been donated through individual research funds from the National Research System ([SNI] by member Dr. Jose Antonio Suarez).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study has approval from the Comite de Bioetica de la Investigacion del Instituto Conmemorativo Gorgas de Estudios de la Salud (260/CBI/ICGES/21).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data has been collected yet.}, URL = {https://www.medrxiv.org/content/early/2021/11/17/2021.10.28.21265606}, eprint = {https://www.medrxiv.org/content/early/2021/11/17/2021.10.28.21265606.full.pdf}, journal = {medRxiv} }